Office of HIV/AIDS, United States Agency for International Development, Washington, DC, USA.
US Centers for Disease Control and Prevention, Atlanta, GA, USA.
J Int AIDS Soc. 2020 Sep;23(9):e25622. doi: 10.1002/jia2.25622.
The COVID-19 pandemic has impacted global health service delivery, including provision of HIV services. Countries with high HIV burden are balancing the need to minimize interactions with health facilities to reduce the risk of COVID-19 transmission, while delivering uninterrupted essential HIV prevention, testing and treatment services. Many of these adaptations in resource-constrained settings have not adequately accounted for the needs of pregnant and breastfeeding women, infants, children and adolescents. We propose whole-family, tailored programme adaptations along the HIV clinical continuum to protect the programmatic gains made in services.
Essential HIV case-finding services for pregnant and breastfeeding women and children should be maintained and include maternal testing, diagnostic testing for infants exposed to HIV, index testing for children whose biological parents or siblings are living with HIV, as well as for children/adolescents presenting with symptoms concerning for HIV and comorbidities. HIV self-testing for children two years of age and older should be supported with caregiver and provider education. Adaptations include bundling services in the same visit and providing testing outside of facilities to the extent possible to reduce exposure risk to COVID-19. Virtual platforms can be used to identify vulnerable children at risk of HIV infection, abuse, harm or violence, and link them to necessary clinical and psychosocial support services. HIV treatment service adaptations for families should focus on family based differentiated service delivery models, including community-based ART initiation and multi-month ART dispensing. Viral load monitoring should not be a barrier to transitioning children and adolescents experiencing treatment failure to more effective ART regimens, and viral load monitoring for pregnant and breastfeeding women and children should be prioritized and bundled with other essential services.
Protecting pregnant and breastfeeding women, infants, children and adolescents from acquiring SARS-CoV-2 while sustaining essential HIV services is an immense global health challenge. Tailored, family friendly programme adaptations for case-finding, ART delivery and viral load monitoring for these populations have the potential to limit SARS-CoV-2 transmission while ensuring the continuity of life-saving HIV case identification and treatment efforts.
COVID-19 大流行对包括提供艾滋病毒服务在内的全球卫生服务提供产生了影响。艾滋病毒负担沉重的国家正在平衡需要,尽量减少与卫生机构的互动,以降低 COVID-19 传播的风险,同时提供不间断的基本艾滋病毒预防、检测和治疗服务。在资源有限的环境中,许多此类调整并没有充分考虑到孕妇和哺乳期妇女、婴儿、儿童和青少年的需求。我们建议沿着艾滋病毒临床连续体对整个家庭进行有针对性的方案调整,以保护在服务中取得的方案成果。
应维持针对孕妇和哺乳期妇女及儿童的基本艾滋病毒病例发现服务,包括孕产妇检测、对接触艾滋病毒的婴儿进行诊断检测、对其亲生父母或兄弟姐妹患有艾滋病毒的儿童进行指标检测,以及对出现与艾滋病毒和合并症相关症状的儿童/青少年进行检测。应通过开展医护人员和提供者培训,支持对 2 岁及以上儿童进行艾滋病毒自我检测。调整包括尽量在一次就诊中提供多项服务,并在设施外进行检测,以降低接触 COVID-19 的风险。虚拟平台可用于识别有感染艾滋病毒、受虐待、受伤害或遭受暴力风险的弱势儿童,并将他们与必要的临床和心理社会支持服务联系起来。针对家庭的艾滋病毒治疗服务调整应侧重于基于家庭的差异化服务提供模式,包括社区启动抗逆转录病毒治疗和多剂量抗逆转录病毒药物配给。病毒载量监测不应成为治疗失败的儿童和青少年转为更有效的抗逆转录病毒治疗方案的障碍,应优先考虑并将病毒载量监测与其他基本服务捆绑在一起。
在保护孕妇和哺乳期妇女、婴儿、儿童和青少年免受 SARS-CoV-2 感染的同时,维持基本的艾滋病毒服务是一项巨大的全球卫生挑战。针对这些人群进行有针对性的、适合家庭的病例发现、抗逆转录病毒治疗提供以及病毒载量监测方案调整有可能限制 SARS-CoV-2 传播,同时确保艾滋病毒病例发现和治疗工作的连续性,挽救生命。